BMI-based barriers to joint replacement in the UK The Lancet Rheumatology ++... ++

BMI-based barriers to joint replacement in the UK The Lancet Rheumatology https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(26)00116-5/fulltext?dgcid=raven_jbs_etoc_email May 2026 Volume 8Number 5e321-e406 https://www.thelancet.com/journals/lanrhe/issue/vol8no5/PIIS2665-9913(26)X2004-5 A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial Anusha Moses, MSca Send email to anusha.moses93@icloud.com ∙ Martijn A H Oude Voshaar, PhDa,b ∙ Eva H van Geel, MDc ∙ Lydia Schipper, PhDd ∙ Iris Rose Peeters, MSce ∙ Reinhard Bos, MDf ∙ et al. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(26)00034-2/abstract?dgcid=raven_jbs_etoc_feature_lanrhe Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab Prof Athimalaipet V Ramanan, FMedScia Send email to a.ramanan@bristol.ac.uk ∙ Prof Nicolino Ruperto, MDb ∙ Ivan Foeldvari, MDc ∙ Gabriel Vega-Cornejo, MDd ∙ Stuart Keller, BSce ∙ Rona Wang, MDe ∙ et al. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00346-7/abstract?dgcid=raven_jbs_etoc_feature_lanrhe